Work

Extended treatment-free hospitalization-free time and quality of life benefits with CAR T-cell therapy in subgroups of patients with relapsed/refractory MM: Insights from the KarMMa-3 trial

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5769

Authors: Krina Patel, Lin Wang, Rashmi Bhatnagar, Roland Marion Gallois, Martina Raggi, Sophie Hello, Paula Rodriguez-Otero

Institutions: The University of Texas MD Anderson Cancer Center, Bristol-Myers Squibb (United States), Syneos Health (United States), Clinica Universidad de Navarra, Universidad de Navarra

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417014407

Cites:

Cited by:

Related to: